Video
11 Oct 2021
PharmaNutra presents: SiderAL, the only Sucrosomial® Iron
Sucrosomial® Technology, designed and patented by PharmaNutra, helps to preserve, transport, protect and facilitate the absorption of certain essential nutrients for the human body, such as iron, selenium, zinc, iodine, calcium and magnesium.
Content provided by our supplier
Pharmanutra SpA
-
IT -
2018On CPHI since
-
3Certificates
-
50 - 99Employees
Company types
Other Content from Pharmanutra SpA (2)
-
News SiderAL Forte 20 capsules best-selling food supplement in Italy
2020 ended positively for Sucrosomial® iron-based products, which thanks to SiderAL® Forte have confirmed their market position. -
Brochure Sucrosomial® Iron: An Updated Review of Its Clinical Efficacy for the Treatment of Iron Deficiency
Iron deficiency (ID) and iron deficiency anemia (IDA) are highly prevalent worldwide. Oral iron salts, especially ferrous sulfate, are commonly used for the treatment of iron deficiency (ID). However, its use is associated with gastrointestinal side effects, thus compromising treatment compliance. Sucrosomial® iron is an oralformulation consisting of ferric pyrophosphate conveyed by a phospholipid and sucrester matrix (sucrosome®).
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance